Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | cimetidine | 2756 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cimetidine | 2756 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | cimetidine | 2756 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | cimetidine | 2756 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cimetidine | 2756 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | cimetidine | 2756 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | sulfathiazole | 5340 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfathiazole | 5340 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfathiazole | 5340 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | sulfathiazole | 5340 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | sulfathiazole | 5340 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | sulfathiazole | 5340 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulfathiazole | 5340 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | sulfathiazole | 5340 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | sulfathiazole | 5340 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | STOCK1N-35215 | None | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | STOCK1N-35215 | None | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | STOCK1N-35215 | None | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | STOCK1N-35215 | None | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | STOCK1N-35215 | None | drug-path |